Home > Products > Betaclav-Kid
DRY SYRUPRx Only

Betaclav-Kid

Amoxycillin & Potassium Clavulanate Oral Suspension IP 228.5 mg

Strong Protection for Little Smiles

Product Overview

BETACLAV-KID Dry Syrup is a broad-spectrum pediatric antibiotic formulation specially developed to treat bacterial infections in younger infants. Calibrated at a balanced 228.5 mg strength, it synergistically blocks beta-lactamase-producing pathogens, resolving painful otitis media, ENT irritation, respiratory distress, and skin infections comfortably.

🔬 Mechanism of Action (Ingredients)

Amoxycillin (200 mg)

  • Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
  • Causes bacterial cell lysis leading to rapid bacterial death.
  • Provides broad-spectrum activity against susceptible Gram-positive and Gram-negative bacteria.
  • Effectively reduces bacterial load and controls infection.

Potassium Clavulanate (28.5 mg)

  • Acts as a beta-lactamase inhibitor, protecting Amoxycillin from enzymatic degradation.
  • Restores the antibacterial activity of Amoxycillin against resistant organisms.
  • Expands the antibacterial spectrum against beta-lactamase-producing bacteria.
  • Enhances overall treatment efficacy and infection clearance.

🎯 Approved Clinical Indications

Ear, Nose & Throat (ENT) Infections
Acute Otitis Media
Respiratory Tract Infections
Tonsillitis & Pharyngitis
Urinary Tract Infections (UTIs)
Skin & Soft Tissue Infections

📦 Product Packaging

Betaclav-Kid product packaging

📊 Clinical Efficacy & Study Data

Comparative clinical charts derived from pharmacokinetics data showing efficacy parameters.

Bacterial Load reduction

1209060300Day 0Day 3Day 5120 CFU40 CFU2 CFU

Recovery Progress (%)

1007550250Day 1Day 3Day 5Day 715%60%90%99%

Bacterial Clearance

1007550250S. Aureus95%S. Pneumo93%H. Influ89%M. Catarrh94%